CJC1295 with DAC

Description

CJC-1295 with DAC – Long-Acting Growth Hormone Releasing Hormone Peptide

CJC-1295 with DAC is a synthetic peptide analog of Growth Hormone Releasing Hormone (GHRH), widely studied in cellular and biochemical research. The DAC (Drug Affinity Complex) modification increases its half-life, making it a long-acting compound in laboratory studies. Researchers use CJC-1295 with DAC to explore growth hormone receptor signaling, peptide interactions, and cellular bioactivity in controlled experimental models.

What Is CJC-1295 with DAC?

CJC-1295 with DAC is a GHRH analog designed for enhanced stability and extended activity in research settings. Its long-acting properties make it ideal for laboratory experiments investigating growth hormone pathways, receptor interactions, and peptide-mediated cellular effects.

Key Research Observations / Benefits

• Supports growth hormone signaling research – widely referenced in in vitro and biochemical studies.

• Long-acting peptide analog – DAC modification provides increased stability for lab experiments.

• Promotes cellular and molecular signaling investigations – valuable for peptide–receptor interaction studies.

• Used in metabolic and endocrine research models – frequently cited in experimental protocols.

Laboratory Applications

CJC-1295 with DAC is primarily used in cell culture, molecular biology, and peptide research, including:

• Growth hormone receptor studies

• Cellular metabolism and protein synthesis research

• Long-acting peptide modeling and pharmacokinetics studies

Experimental concentrations are determined according to in vitro protocols and cell type, typically in nanomolar to micromolar ranges.

Product Highlights

• High-purity CJC-1295 with DAC peptide for research use

• Water-soluble and laboratory-ready formulation

• No fillers, additives, or excipients

• Manufactured to strict research-grade quality standards

Important Notice:
This product is intended for research and educational purposes only.
Not for human consumption, medical use, or diagnostic purposes.

CJC-1295 with DAC is a synthetic Growth Hormone-Releasing Hormone (GHRH) analog
modified with a Drug Affinity Complex (DAC) to significantly extend its half-life.
In laboratory research, this peptide is used to study the long-term stimulation of
growth hormone (GH) and IGF-1 secretion via the GHRH receptor . CJC-1295 with DAC is manufactured to high laboratory standards and verified by
High-Performance Liquid Chromatography (HPLC) to ensure ≥ 99% purity.
Each batch is intended exclusively for controlled in vitro endocrinological and biochemical testing.

Important specifications

Application & Use (for research purposes only)

• For in vitro research purposes only .
• Not suitable for human or animal consumption or medical use.
• To be used for endocrine and biochemical research on growth hormone release and receptor activity.